Katharine Epler
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Katharine Epler has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Alexandra G. Moyzis
Salk Institute for Biological Sciences, La Jolla, California, USA
1 shared publication - Alice Shen
Department of Medicine, School of Medicine, UCSD, La Jolla, California, USA
1 shared publication - Alva G. Sainz
Salk Institute for Biological Sciences, La Jolla, California, USA
1 shared publication - Avnee J. Kumar
Division of Pulmonary, Critical Care, Sleep Medicine & Physiology, San Diego (UCSD), University of California, San Diego, USA
1 shared publication - Gerald S. Shadel
Salk Institute for Biological Studies, La Jolla, CA, USA
1 shared publication - Helen Goodluck
VA San Diego Healthcare System, San Diego, California, USA
1 shared publication
Latest Publications
- Open Access
- 21 October 2025
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 10 (23)
Kidney mitochondrial DNA contributes to systemic IL-6 release in sepsis-associated acute kidney injury
Mitochondrial dysfunction is a major mechanism of acute kidney injury (AKI), and increased circulating interleukin 6 (IL-6) is associated with systemic inflammation and death due to sepsis. We tested whether kidney mitochondrial DNA (mtDNA) contributes to IL-6 release in sepsis-associated AKI via Toll-like receptor 9 (TLR9). In a murine model of sepsis via cecal ligation and puncture (CLP), we used next-generation sequencing of plasma mtDNA to inform the design of optimal target sequences for quantification by droplet digital PCR, and to identify single-nucleotide polymorphisms (SNPs) to infer tissue origin. We found significantly higher concentrations of plasma mtDNA after CLP versus shams and that plasma mtDNA SNPs matched kidney SNPs more than other organs. Kidney mtDNA contributed directly to IL-6 and mtDNA release from dendritic cells in vitro and kidney mitochondria solution led to higher IL-6 concentrations in vivo. IL-6 release was mitigated by a TLR9 inhibitor. Finally, plasma mtDNA was significantly higher in septic patients with AKI compared with those without AKI and correlated significantly with plasma IL-6. We conclude that AKI contributes to increased circulating IL-6 in sepsis via mtDNA release. Targeting kidney mitochondria and mtDNA release are potential translational avenues to decrease mortality from sepsis-associated AKI.
- 21 October 2025
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 10 (23)
Open AccessKidney mitochondrial DNA contributes to systemic IL-6 release in sepsis-associated acute kidney injury
Mitochondrial dysfunction is a major mechanism of acute kidney injury (AKI), and increased circulating interleukin 6 (IL-6) is associated with systemic inflammation and death due to sepsis. We tested whether kidney mitochondrial DNA (mtDNA) contributes to IL-6 release in sepsis-associated AKI via Toll-like receptor 9 (TLR9). In a murine model of sepsis via cecal ligation and puncture (CLP), we used next-generation sequencing of plasma mtDNA to inform the design of optimal target sequences for quantification by droplet digital PCR, and to identify single-nucleotide polymorphisms (SNPs) to infer tissue origin. We found significantly higher concentrations of plasma mtDNA after CLP versus shams and that plasma mtDNA SNPs matched kidney SNPs more than other organs. Kidney mtDNA contributed directly to IL-6 and mtDNA release from dendritic cells in vitro and kidney mitochondria solution led to higher IL-6 concentrations in vivo. IL-6 release was mitigated by a TLR9 inhibitor. Finally, plasma mtDNA was significantly higher in septic patients with AKI compared with those without AKI and correlated significantly with plasma IL-6. We conclude that AKI contributes to increased circulating IL-6 in sepsis via mtDNA release. Targeting kidney mitochondria and mtDNA release are potential translational avenues to decrease mortality from sepsis-associated AKI.